IMM2510

· ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for IMM2510, covering 2024-12-24 to 2025-09-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IMM2510 + IMM01 Combination Therapy in Patients With Advanced Solid Tumors [Phase 1, Phase 2]